Care-banner-mobile

Cipla Sustainability

Sustainability

Our approach to responsible resource consumption, efforts to enhance access and affordability of medicines worldwide and strong financial growth, provide a robust foundation to build a responsible business.

child-video-image
leaf-image
icon-growth
8% CAGR
of Revenue over the last 5 Years
5.9% R&D Investment
icon-microscope
icon-bag
₹ 22,753 Crores Revenue from Operations
cipla-sustainability
image-cipla-house

Manufacturing Highlights

Our investments in manufacturing capital include development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments and strengthening of platform technologies.

About-ManufacturingFacility

 

30.54 Billion
Tablets and capsules
About-1500PlusProducts_0

 

125.80 Million
Aerosol pMDI
About-26000PlusEmployee

 

1.63 Million
Lyophilised injections
About-1300PlusScientists

 

773.60 Million
Repsules
About-HealthcareAndPharmacistsNetwork

 

48 Million
Nasal sprays
About-HealthcareAndPharmacistsNetwork

 

51.60 Million
Oral liquids
About-HealthcareAndPharmacistsNetwork

 

2.50 Million
Form-fill seal eye-drops
Lighthouse-image-desktop
committees
COMMITTEES
OF BOARD
Learn More
milestone
MILESTONE
AWARDS
Learn More